Summary
Spasticity has been described as “a motor disorder, characterized by a velocity-dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyper-excitability of the stretch reflex as one component of the upper motor neuron syndrome”. In patients with complete spinal cord lesions, severe untreatable spasticity can make movement, sitting and hygiene difficult or impossible while it may alter gait and personal care in patients with partial lesions. From a clinical point of view, it is useful to distinguish spinal cord spasticity from supraspinal spasticity. Traditionally, the Ashworth scale is the most widely used to quantify the tone of single muscles. In order to quantify hypereflexia, the Reflex Scale is also used. In the spinal spasticity which is characterized by spasms, the Spasm Frequency Scale is useful in order to monitor their frequency. Initially, management of spasticity is based on non-invasive treatments that later become more invasive. The first approach, the conservative treatment, usually includes elimination of the nociceptive stimuli, rehabilitative therapy (physical and occupational), orthopaedic prostheses and plaster corsets. These treatments, do not resolve spasticity in about 33% of cases. In these severe cases, more invasive procedures such as muscle infiltrations with botulin toxin and intrathecal baclofen infusion can be used.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265: 1418–1422
Albright AL, Barry MJ, Painter MJ, Schultz B (1998) Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 88: 73–76
Barnes MP, Kent RM, Semlyen JK, McMullen KM (2003) Spasticity in multiple sclerosis. Neurorehabil Neural Repair 17: 66–70
Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244(3): 160–166
Bramanti P, D’Aleo G, Rifici C, Alagna A, Cannata A, Sessa E, Di Bella P, Marra G (2004) Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales. Funct Neurol 19(4): 227–231
Bramanti P, Sessa E, Rifici C, D’Aleo G, Floridia D, Di Bella P, Lublin F (1998) Enhanced spasticity in primary progressive MS patients treated with interferon beta 1b. Neurology 51: 1720–1723
Coffey JR, Cahill D, Steers W et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78: 226–232
Dabney KW, Lipton GE, Miller F (1997) Cerebral palsy. Curr Opin Pediatr 9(1): 81–88 (review)
Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88(6): 1009–1013
Jarret L, Nandi P, Thompson AJ (2002) Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J Neurol Neurosurg Psychiatry 73: 705–709
Lance JW (1980) The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 30(12): 1303–1313
Müller H (1992) Treatment of severe spasticity: results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system. Dev Med Child Neurol 3: 739–745
Nance P, Schryvers O, Schmidt B, Dubo H, Loveridge B, Fewer D (1995) Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 22(1): 22–29
Nielsen JF, Sinkjaer T (2004) Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump. Mult Scler 10(5): 521–525
Ochs G, Struppler A, Meyerson BA, Linderoth B, Bybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 52: 933–939
Ordia JI, Fischer E, Adamski E, Spatz EL (1996) Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 85(3): 452–457
Penn RD, Kroin JS (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77: 236–240
Penn RD, Savoy SM, Corcos D (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320: 1517–1521
Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10: 589–595
Saltuari L, Kofler M, Kepplinger B, Russegger L, Schmutzhard E, Aichner F (1990) Treatment of spinal and supraspinal spasticity by intrathecal administration of baclofen using a computer-assisted pump system. Biomed Tech (Berl) 35[Suppl 2]: 131–132 (German)
Saltuari L, Kronenberg M, Marosi MG, Kofler M, Rifici C, Bramanti P (1992) Indication, efficiency and complications of intrathecal baclofen treatment in spinal spasticity. Acta Neurol 14: 187–194
Saltuari L, Schmutzard E, Kofler M, Baumgartner H, Aichner F, Gerstenbrand F (1989) Intrathecal baclofen for intractable spasticity due to severe brain injury. Lancet 2: 503–504
Smith PF (2002) Cannabinoids in the treatment of pain and spasticity in multiple sclerosis. Curr Opin Investig Drugs 3: 859–864
Thompson AJ (1996) Multiple sclerosis: symptomatic treatment. J Neurol 243: 559–565
Wilson PR, Yaksh TL (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 15; 51(4): 323–330
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag
About this chapter
Cite this chapter
Marra, G.A., D’Aleo, G., Di Bella, P., Bramanti, P. (2007). Intrathecal baclofen therapy in patients with severe spasticity. In: Sakas, D.E., Simpson, B.A., Krames, E.S. (eds) Operative Neuromodulation. Acta Neurochirurgica Supplements, vol 97/1. Springer, Vienna. https://doi.org/10.1007/978-3-211-33079-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-211-33079-1_23
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-33078-4
Online ISBN: 978-3-211-33079-1
eBook Packages: MedicineMedicine (R0)